Protalix BioTherapeutics, Inc. (PLX) Cost of Revenue USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from 2010 to 2024.
  • Protalix BioTherapeutics, Inc. Cost of Revenue for the quarter ending March 31, 2024 was $2.6 M, a 15.7% decline year-over-year.
  • Protalix BioTherapeutics, Inc. Cost of Revenue for the twelve months ending March 31, 2024 was $22.5 M, a 35.2% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2023 was $23 M, a 17.3% increase from 2022.
  • Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2022 was $19.6 M, a 19.8% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2021 was $16.3 M, a 50.4% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $22.5 M $2.6 M -$483 K -15.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $23 M $8.86 M +$6.46 M +269% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $16.5 M $4.89 M -$2.18 M -30.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $18.7 M $6.15 M +$2.06 M +50.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $16.6 M $3.09 M -$2.95 M -48.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $19.6 M $2.4 M -$751 K -23.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $20.3 M $7.07 M +$3.37 M +91% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $17 M $4.09 M -$646 K -13.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $17.6 M $6.03 M +$1.27 M +26.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $16.3 M $3.15 M +$396 K +14.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 $16 M $3.7 M +$835 K +29.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $15.1 M $4.73 M +$2.91 M +159% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $12.2 M $4.77 M +$1.34 M +39.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $10.9 M $2.75 M -$198 K -6.71% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $11.1 M $2.87 M -$337 K -10.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $11.4 M $1.83 M -$868 K -32.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $12.3 M $3.43 M +$1.38 M +67.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $10.9 M $2.95 M +$672 K +29.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 $10.2 M $3.21 M +$1.29 M +67.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $8.94 M $2.7 M +$512 K +23.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $8.42 M $2.05 M -$879 K -30.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-01
Q4 2018 $9.3 M $2.28 M +$724 K +46.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-30
Q3 2018 $8.58 M $1.92 M -$4.15 M -68.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $12.7 M $2.18 M -$3.34 M -60.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $16.1 M $2.92 M +$836 K +40% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $15.2 M $1.55 M -$398 K -20.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $15.6 M $6.07 M +$1.82 M +42.8% Jul 1, 2017 Sep 30, 2017 10-Q/A 2019-03-18
Q2 2017 $13.8 M $5.52 M +$3.85 M +230% Apr 1, 2017 Jun 30, 2017 10-Q/A 2019-03-18
Q1 2017 $9.96 M $2.09 M +$1.57 M +299% Jan 1, 2017 Mar 31, 2017 10-Q/A 2019-03-18
Q4 2016 $8.4 M $1.95 M +$1.95 M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $6.45 M $4.25 M +$4.03 M +1805% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $2.42 M $1.68 M +$1.45 M +644% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $971 K $523 K +$241 K +85.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $730 K $0 +$6.85 M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 -$6.12 M $223 K -$1.58 M -87.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$4.54 M $225 K -$1.38 M -86% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$3.16 M $282 K -$3.79 M -93.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $630 K -$6.85 M -$2.97 M -76.6% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $3.6 M $1.8 M +$211 K +13.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $3.39 M $1.61 M +$287 K +21.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $3.1 M $4.07 M +$3.1 M +319% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $0 -$3.88 M -$5.05 M -429% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-08
Q3 2013 $5.05 M $1.59 M -$780 K -33% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $5.83 M $1.32 M -$1.96 M -59.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $7.8 M $971 K -$349 K -26.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $8.14 M $1.18 M +$783 K +198% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $7.36 M $2.37 M +$2.15 M +976% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $5.21 M $3.28 M +$3.15 M +2384% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $2.07 M $1.32 M +$542 K +69.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $1.53 M $395 K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 $220 K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $132 K +$132 K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 $778 K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q2 2010 $0 Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.